PH12021552573A1 - Long-term stable live fecal microbiota composition - Google Patents
Long-term stable live fecal microbiota compositionInfo
- Publication number
- PH12021552573A1 PH12021552573A1 PH1/2021/552573A PH12021552573A PH12021552573A1 PH 12021552573 A1 PH12021552573 A1 PH 12021552573A1 PH 12021552573 A PH12021552573 A PH 12021552573A PH 12021552573 A1 PH12021552573 A1 PH 12021552573A1
- Authority
- PH
- Philippines
- Prior art keywords
- composition
- long
- term stable
- fecal microbiota
- microbiota composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 241000736262 Microbiota Species 0.000 title 1
- 230000002550 fecal effect Effects 0.000 title 1
- 230000007774 longterm Effects 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382287 | 2019-04-15 | ||
| PCT/EP2020/060370 WO2020212297A1 (en) | 2019-04-15 | 2020-04-14 | Long-term stable live fecal microbiota composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12021552573A1 true PH12021552573A1 (en) | 2022-07-04 |
Family
ID=66349477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2021/552573A PH12021552573A1 (en) | 2019-04-15 | 2020-04-14 | Long-term stable live fecal microbiota composition |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20220143107A1 (https=) |
| EP (2) | EP3955899B1 (https=) |
| JP (1) | JP2022529008A (https=) |
| KR (1) | KR20210152505A (https=) |
| CN (1) | CN113710237B (https=) |
| AU (1) | AU2020259740B2 (https=) |
| BR (1) | BR112021020606A2 (https=) |
| CA (1) | CA3130816A1 (https=) |
| DK (1) | DK3955899T3 (https=) |
| EA (1) | EA202192291A1 (https=) |
| ES (1) | ES3035981T3 (https=) |
| FI (1) | FI3955899T3 (https=) |
| IL (1) | IL287238A (https=) |
| MX (1) | MX2021011246A (https=) |
| PH (1) | PH12021552573A1 (https=) |
| PL (1) | PL3955899T3 (https=) |
| PT (1) | PT3955899T (https=) |
| SG (1) | SG11202110641XA (https=) |
| WO (1) | WO2020212297A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017024265B1 (pt) | 2015-05-11 | 2022-08-09 | Mybiotics Pharma Ltd | Métodos para crescimento de um biofilme de bactérias probióticas em partículas sólidas |
| IL294171A (en) | 2016-05-25 | 2022-08-01 | Mybiotics Pharma Ltd | Composition and methods for microbiota therapy |
| EP3955899B1 (en) | 2019-04-15 | 2025-05-07 | Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) | Long-term stable live microbiota composition |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1190386A (en) * | 1966-06-28 | 1970-05-06 | Green Cross Corp | Process for producing the Lactic Acid Bacteria Drugs |
| FR2708621B1 (fr) * | 1993-07-29 | 1995-10-20 | Lesaffre & Cie | Biomasse stable à base de cellules de levure et de bactéries lactiques et procédé de préparation. |
| ITMI20011632A1 (it) | 2001-07-27 | 2003-01-27 | Sanofi Synthelabo | Composizione solida contenente spore di batteri non patogeni del genere bacillus |
| US20050266069A1 (en) | 2002-09-06 | 2005-12-01 | Simmons Donald L | Stable probiotic microsphere compositions and their methods of preparation |
| US20050100559A1 (en) * | 2003-11-07 | 2005-05-12 | The Procter & Gamble Company | Stabilized compositions comprising a probiotic |
| GB0330009D0 (en) * | 2003-12-24 | 2004-01-28 | Ferrosan As | Probiotic tablet formulations |
| CA2623968C (en) | 2005-09-29 | 2014-12-09 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Method for stabilising pharmaceutical administration forms comprising microorganisms |
| DE102005062731A1 (de) * | 2005-12-22 | 2007-06-28 | Organobalance Gmbh | Neue Lactobacillus Stämme und deren Verwendung |
| TR200800634A2 (tr) * | 2008-01-30 | 2009-02-23 | Takka Sevgi̇ | Uzatılmış salım sağlayan fluvastatin tablet. |
| CA2808610C (en) * | 2010-08-10 | 2018-09-25 | R.P. Scherer Technologies, Llc | Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria |
| CN104095180A (zh) * | 2013-04-12 | 2014-10-15 | 中国科学院烟台海岸带研究所 | 一种益生菌菊粉片及其制备方法 |
| US10583420B2 (en) * | 2014-10-01 | 2020-03-10 | 7905122 Canada Inc. | Process and apparatus for manufacturing water-absorbing material and use in cat litter |
| WO2016178775A1 (en) * | 2015-05-01 | 2016-11-10 | Microbiome Health Research Institute Inc. | Compositions and methods for therapeutic delivery of microbial communities |
| CN104922158B (zh) * | 2015-06-05 | 2018-11-02 | 中国人民解放军第三军医大学第三附属医院 | 粪菌胶囊及其制备与应用 |
| US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| CN109414048B (zh) * | 2016-06-30 | 2023-09-01 | 弗门尼舍有限公司 | 包衣酵母配方 |
| US20200147151A1 (en) * | 2017-01-30 | 2020-05-14 | The Board Of Regents Of The University Of Texas System | Compositions and methods for fecal microbiota transplantation |
| US20200188310A1 (en) | 2017-08-29 | 2020-06-18 | Chr. Hansen A/S | Stable capsules with fecal microbiota or a culture of microorganisms |
| CN108567799A (zh) * | 2018-08-01 | 2018-09-25 | 中国人民解放军总医院 | 一种全粪菌复合胶囊及其制备方法和应用 |
| EP3955899B1 (en) | 2019-04-15 | 2025-05-07 | Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) | Long-term stable live microbiota composition |
-
2020
- 2020-04-14 EP EP20716843.6A patent/EP3955899B1/en active Active
- 2020-04-14 WO PCT/EP2020/060370 patent/WO2020212297A1/en not_active Ceased
- 2020-04-14 DK DK20716843.6T patent/DK3955899T3/da active
- 2020-04-14 MX MX2021011246A patent/MX2021011246A/es unknown
- 2020-04-14 FI FIEP20716843.6T patent/FI3955899T3/fi active
- 2020-04-14 BR BR112021020606A patent/BR112021020606A2/pt unknown
- 2020-04-14 PH PH1/2021/552573A patent/PH12021552573A1/en unknown
- 2020-04-14 SG SG11202110641XA patent/SG11202110641XA/en unknown
- 2020-04-14 PT PT207168436T patent/PT3955899T/pt unknown
- 2020-04-14 KR KR1020217036103A patent/KR20210152505A/ko active Pending
- 2020-04-14 CN CN202080029290.6A patent/CN113710237B/zh active Active
- 2020-04-14 ES ES20716843T patent/ES3035981T3/es active Active
- 2020-04-14 AU AU2020259740A patent/AU2020259740B2/en active Active
- 2020-04-14 EA EA202192291A patent/EA202192291A1/ru unknown
- 2020-04-14 EP EP25174121.1A patent/EP4609873A3/en active Pending
- 2020-04-14 US US17/602,134 patent/US20220143107A1/en active Pending
- 2020-04-14 PL PL20716843.6T patent/PL3955899T3/pl unknown
- 2020-04-14 CA CA3130816A patent/CA3130816A1/en active Pending
- 2020-04-14 JP JP2021561644A patent/JP2022529008A/ja active Pending
-
2021
- 2021-10-13 IL IL287238A patent/IL287238A/en unknown
-
2023
- 2023-12-15 US US18/541,995 patent/US12521422B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210152505A (ko) | 2021-12-15 |
| EP4609873A2 (en) | 2025-09-03 |
| EP3955899B1 (en) | 2025-05-07 |
| PT3955899T (pt) | 2025-07-18 |
| EA202192291A1 (ru) | 2022-02-11 |
| DK3955899T3 (da) | 2025-08-04 |
| BR112021020606A2 (pt) | 2021-12-07 |
| AU2020259740B2 (en) | 2025-12-18 |
| AU2020259740A1 (en) | 2021-10-28 |
| MX2021011246A (es) | 2022-01-18 |
| IL287238A (en) | 2021-12-01 |
| SG11202110641XA (en) | 2021-10-28 |
| JP2022529008A (ja) | 2022-06-16 |
| EP4609873A3 (en) | 2025-11-12 |
| CN113710237A (zh) | 2021-11-26 |
| CN113710237B (zh) | 2026-04-03 |
| WO2020212297A1 (en) | 2020-10-22 |
| EP3955899A1 (en) | 2022-02-23 |
| US20240131085A1 (en) | 2024-04-25 |
| FI3955899T3 (fi) | 2025-07-28 |
| US12521422B2 (en) | 2026-01-13 |
| PL3955899T3 (pl) | 2025-09-22 |
| CA3130816A1 (en) | 2020-10-22 |
| ES3035981T3 (en) | 2025-09-11 |
| US20220143107A1 (en) | 2022-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015157559A3 (en) | 10',11'-modified saxitoxins useful for the treatment of pain | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| MX2010002392A (es) | Composiciones de brimonidina mejoradas para tratar eritema. | |
| PH12021552573A1 (en) | Long-term stable live fecal microbiota composition | |
| NZ606825A (en) | Methods and compositions for treating complement-associated disorders | |
| EA200701519A1 (ru) | Живая аттенуированная ротавирусная вакцина для перорального введения | |
| MX2009010977A (es) | Metodos de administracion de tetrahidrobiopterina, composiciones asociadas y metodos de medicion. | |
| SI1644009T1 (en) | COMPOSITION TO INCREASE TELECOMMUNICATION ACTIVITY AND TREATMENT OF HIV INFECTION | |
| SG146648A1 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
| ITBO20110012A1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| MY148690A (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
| SG166093A1 (en) | Inhibitors of brutonæs tyrosine kinase | |
| TN2009000457A1 (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
| EA201071039A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40 | |
| BR112013010829B8 (pt) | Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação | |
| PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
| JP2017526695A5 (https=) | ||
| MX2022006742A (es) | Uso y composicion farmaceutica de derivados de fenilisoxazolil metilen-naftaleno-eter. | |
| JP2008534503A5 (https=) | ||
| EP2575456A4 (en) | COMPOSITIONS AND METHODS FOR TREATING PRESENTATIONS | |
| EP4327815A3 (en) | Probiotics for regulating blood glucose | |
| MX2023005875A (es) | Formas solidas de 3-(5-fluorobenzofuran-3-il)-4-(5-metil-5h-[1,3]d ioxolo[4,5-f]indol-7-il)pirrol-2,5-diona. | |
| NZ600187A (en) | Pharmaceutical composition for treating cutaneous burns | |
| HRP20190562T1 (hr) | Sastavi za liječenje zaraze srčanim crvom |